Amicogen Inc (092040) - Total Liabilities

Latest as of December 2025: ₩136.00 Billion KRW ≈ $92.17 Million USD

Based on the latest financial reports, Amicogen Inc (092040) has total liabilities worth ₩136.00 Billion KRW (≈ $92.17 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Amicogen Inc (092040) cash conversion ratio to assess how effectively this company generates cash.

Amicogen Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Amicogen Inc's total liabilities have evolved over time, based on quarterly financial data. Check 092040 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Amicogen Inc Competitors by Total Liabilities

The table below lists competitors of Amicogen Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Invesco High Income Trust II NYSE:VLT	USA	$31.06 Million
Marchex Inc NASDAQ:MCHX	USA	$9.60 Million
Envirosuite Limited F:57P	Germany	€34.22 Million
Dreadnought Resources Ltd AU:DRE	Australia	AU$1.22 Million
Feelux Co. Ltd. KO:033180	Korea	₩563.86 Billion
Export Packing KO:002200	Korea	₩59.07 Billion
Enertork Ltd KQ:019990	Korea	₩8.34 Billion
NEW ZEALAND RURAL F:8UK	Germany	€216.89 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Amicogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 092040 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.47	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Amicogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Amicogen Inc (2014–2025)

The table below shows the annual total liabilities of Amicogen Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩136.00 Billion ≈ $92.17 Million	-20.80%
2024-12-31	₩171.73 Billion ≈ $116.38 Million	-30.79%
2023-12-31	₩248.12 Billion ≈ $168.15 Million	-16.70%
2022-12-31	₩297.86 Billion ≈ $201.85 Million	+32.34%
2021-12-31	₩225.06 Billion ≈ $152.52 Million	+72.56%
2020-12-31	₩130.43 Billion ≈ $88.39 Million	+9.28%
2019-12-31	₩119.35 Billion ≈ $80.88 Million	+14.84%
2018-12-31	₩103.93 Billion ≈ $70.43 Million	+39.83%
2017-12-31	₩74.32 Billion ≈ $50.37 Million	+14.71%
2016-12-31	₩64.79 Billion ≈ $43.91 Million	-16.65%
2015-12-31	₩77.74 Billion ≈ $52.68 Million	+1688.10%
2014-12-31	₩4.35 Billion ≈ $2.95 Million	--

About Amicogen Inc

KQ:092040 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$67.86 Million

₩100.14 Billion KRW

Market Cap Rank

#20691 Global

#1246 in Korea

Share Price

₩1812.00

Change (1 day)

-3.87%

52-Week Range

₩1175.00 - ₩4690.00

All Time High

₩22094.22